In This Section
Neal Rosen, MD, PhD

Neal Rosen, MD, PhD

Memorial Sloan Kettering Cancer Center
New York, New York 

Class of 2022

Scientific Areas of Expertise: Mechanism-based Combination Therapies, Mitogenic Signaling Pathways, Oncogene-induced Signaling Networks

For pioneering work dedicated to elucidating cell signaling mechanisms responsible for human cancers, identifying oncoprotein-dependent feedback inhibition of signaling networks as an important factor in tumor evolution and in the clinical response to targeted inhibitors, characterizing the functional classes of BRAF mutants, and developing numerous inhibitors of malignant transformation by targeting the RAS-RAF-MEK-ERK and PI3K-AKT-mTOR pathways.